Insider · CIK 0001187572

HENNEMAN JOHN B III

Reports to the SEC for 8 companies · BEDFORD, MA

sec.gov

Transactions

Companies

Filings

CIK

0001187572

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-06-18	ANIKAnika Therapeutics, Inc.A Award	Director	AAward	+10.4K sh	—	—	65,273
2026-06-16	APREAprea Therapeutics, Inc. · Stock Options (Right to Buy)A Award	Director	AAward	+12.6K sh	—	—	12,555
2026-06-16	APREAprea Therapeutics, Inc.A Award	Director	AAward	+3,135 sh	—	—	13,364
2026-06-10	OFIXOrthofix Medical Inc.A Award	Director	AAward	+15K sh	—	—	105,774
2026-05-07	OFIXOrthofix Medical Inc.P Purchase	Director	PPurchase	+5,000 sh	$12.26	+$61.3K	90,809
2026-05-01	ANIKAnika Therapeutics, Inc.P Purchase	Director	PPurchase	+5,000 sh	$14.66	+$73.3K	54,871
2025-06-20	ANIKAnika Therapeutics, Inc.A Award	Director	AAward	+14.2K sh	—	—	49,871
2025-06-18	OFIXOrthofix Medical Inc.A Award	Director	AAward	+18.8K sh	—	—	83,706
2025-06-05	APREAprea Therapeutics, Inc. · Stock Options (Right to Buy)A Award	Director	AAward	+4,185 sh	—	—	4,185
2025-06-05	APREAprea Therapeutics, Inc.A Award	Director	AAward	+1,045 sh	—	—	10,229
2024-11-19	R1 RCM Inc. /DED Disposition to Issuer	Director	DDisposition to Issuer	−87.8K sh	$14.30	−$1.26M	0
2024-11-19	R1 RCM Inc. /DEDirector Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−516K sh	—	—	0
2024-07-09	ANIKAnika Therapeutics, Inc.A Award	Director	AAward	+5,771 sh	—	—	35,707
2024-06-20	APREAprea Therapeutics, Inc. · Stock Options (Right to Buy)A Award	Director	AAward	+4,185 sh	—	—	4,185
2024-06-20	APREAprea Therapeutics, Inc.A Award	Director	AAward	+1,045 sh	—	—	9,184
2024-06-18	OFIXOrthofix Medical Inc.A Award	Director	AAward	+15.2K sh	$12.87	+$195K	63,914
2024-05-23	R1 RCM Inc. /DEA Award	Director	AAward	+15.7K sh	—	—	87,765
2024-03-13	APREAprea Therapeutics, Inc. · Tranche B WarrantP Purchase	Director	PPurchase	+3,430 sh	—	—	3,430
2024-03-13	APREAprea Therapeutics, Inc. · Tranche A WarrantP Purchase	Director	PPurchase	+3,430 sh	—	—	3,430
2024-03-13	APREAprea Therapeutics, Inc.P Purchase	Director	PPurchase	+6,860 sh	$7.29	+$50K	8,139
2023-08-23	APREAprea Therapeutics, Inc. · Stock Options (Right to Buy)A Award	Director	AAward	+2,000 sh	—	—	2,000
2023-08-23	APREAprea Therapeutics, Inc.A Award	Director	AAward	+500 sh	—	—	1,279
2023-08-08	R1 RCM Inc. /DEDirector Stock Option (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−50K sh	—	—	355,111
2023-08-08	R1 RCM Inc. /DEM Exercise/Conversion	Director	MExercise/Conversion	+50K sh	$2.61	+$131K	122,114
2023-08-08	R1 RCM Inc. /DES Sale	Director	SSale	−50K sh	$17.17	−$859K	72,114
2023-06-14	ANIKAnika Therapeutics, Inc.A Award	Director	AAward	+6,500 sh	—	—	29,936
2023-05-18	R1 RCM Inc. /DEA Award	Director	AAward	+11.3K sh	—	—	72,114
2023-01-05	SeaSpine Holdings CorpStock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−3,858 sh	—	—	0
2023-01-05	SeaSpine Holdings CorpStock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−13.9K sh	—	—	0
2023-01-05	OFIXOrthofix Medical Inc.A Award	Director	AAward	+14.1K sh	—	—	48,460
2023-01-05	SeaSpine Holdings CorpD Disposition to Issuer	Director	DDisposition to Issuer	−82.7K sh	—	—	0
2023-01-05	SeaSpine Holdings CorpStock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−58.6K sh	—	—	0
2023-01-05	OFIXOrthofix Medical Inc.A Award	Director	AAward	+14.4K sh	—	—	48,762
2022-07-28	APREAprea Therapeutics, Inc. · Stock Option (right to Buy)A Award	Director	AAward	+29.6K sh	—	—	29,575
2022-07-28	APREAprea Therapeutics, Inc.A Award	Director	AAward	+5,995 sh	—	—	15,605
2022-06-21	R1 RCM Inc. /DEDirector Stock Option (right to buy)A Award	Director	AAward	+405K sh	—	—	405,111
2022-06-21	R1 RCM Inc. /DEA Award	Director	AAward	+60.8K sh	—	—	60,790
2022-06-21	R1 RCM Holdco Inc.Director Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−15.4K sh	—	—	0
2022-06-21	R1 RCM Holdco Inc.Director Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−13.8K sh	—	—	0
2022-06-21	R1 RCM Holdco Inc.Director Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−14.1K sh	—	—	0
2022-06-21	R1 RCM Holdco Inc.Director Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−9,169 sh	—	—	0
2022-06-21	R1 RCM Holdco Inc.Director Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−3,871 sh	—	—	0
2022-06-21	R1 RCM Inc. /DEDirector Stock Option (right to buy)A Award	Director	AAward	+9,678 sh	—	—	9,678
2022-06-21	R1 RCM Inc. /DEDirector Stock Option (right to buy)A Award	Director	AAward	+12K sh	—	—	12,048
2022-06-21	R1 RCM Holdco Inc.Director Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−12K sh	—	—	0
2022-06-21	R1 RCM Inc. /DEDirector Stock Option (right to buy)A Award	Director	AAward	+7,697 sh	—	—	7,697
2022-06-21	R1 RCM Inc. /DEDirector Stock Option (right to buy)A Award	Director	AAward	+1,965 sh	—	—	1,965
2022-06-21	R1 RCM Inc. /DEDirector Stock Option (right to buy)A Award	Director	AAward	+9,169 sh	—	—	9,169
2022-06-21	R1 RCM Inc. /DEDirector Stock Option (right to buy)A Award	Director	AAward	+1,424 sh	—	—	1,424
2022-06-21	R1 RCM Holdco Inc.D Disposition to Issuer	Director	DDisposition to Issuer	−54.8K sh	—	—	0

Recent filings

Accepted (ET)
Jun 234
HENNEMAN JOHN B III0001193125-26-279542
SEC(opens sec.gov)
Jun 174
HENNEMAN JOHN B III0001104659-26-075282
SEC(opens sec.gov)
Jun 124
HENNEMAN JOHN B III0001193125-26-269865
SEC(opens sec.gov)
May 84
HENNEMAN JOHN B III0001193125-26-214850
SEC(opens sec.gov)
May 44
HENNEMAN JOHN B III0001193125-26-202704
SEC(opens sec.gov)
Jun 244
HENNEMAN JOHN B III0001171843-25-004067
SEC(opens sec.gov)
Jun 234
HENNEMAN JOHN B III0000950170-25-088989
SEC(opens sec.gov)
Jun 94
HENNEMAN JOHN B III0001104659-25-057815
SEC(opens sec.gov)
Nov 194
HENNEMAN JOHN B III0000950170-24-128856
SEC(opens sec.gov)
Jul 114
HENNEMAN JOHN B III0001171843-24-003906
SEC(opens sec.gov)
Jun 214
HENNEMAN JOHN B III0001104659-24-073941
SEC(opens sec.gov)
Jun 204
HENNEMAN JOHN B III0000950170-24-075301
SEC(opens sec.gov)
May 234
HENNEMAN JOHN B III0001628280-24-025050
SEC(opens sec.gov)
Mar 144
HENNEMAN JOHN B III0001104659-24-034671
SEC(opens sec.gov)

Companies

Address

C/O ANIKA THERAPEUTICS, INC. 32 WIGGINS AVENUE

BEDFORD, MA, 01730